If you wish scientists would figure out a solution for a medical problem you face, or find answers for a loved one who struggles with a health condition, here’s your chance.
The University of Michigan wants your ideas for what its medical researchers should study. You can also lend your voice to ideas suggested by other members of the public, and help them gain steam.
And once a U-M researcher agrees to take up the idea and run with it, you can help make the research happen by donating online or volunteering to take part. U-M will even kick in funds for the hottest ideas.
James Shayman, M.D., one of two U-M scientists who led the development of the drug eliglustat tartrate, now sold as Cerdelga
It took more than 40 years, and a lot of dedication. But an idea born and nurtured in University of Michigan laboratories is now making a difference in the lives of patients with a rare disease.
For one of the first times, a drug developed first at U-M, and then further by a company, made it through all the steps it takes to reach patients around the world.
And even though the disease it treats only affects about 10,000 people worldwide, it’s become a product that a company can sell and doctors can prescribe to their patients. In this case, it’s patients with the debilitating and potentially fatal rare condition called Gaucher disease.
“My mom knew since my birth that something wrong was going on, but didn’t know what exactly,” says Daizha Hill, now 16 years old. “She kept a book where she would write down every symptom I was having when I didn’t feel good. Then she would try to look them up online to see what she could find out.”
Daizha and her mother, Juanita Brooks-Hill, went to several doctors in the Metro Detroit area looking for answers to her symptoms. Meanwhile, Juanita kept searching online for experts that helped patients with symptoms that matched what Daizha was experiencing.
That’s when she stumbled across Dr. Elif Oral, an endocrinologist, on the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) website. After further searching, she found that Dr. Oral had recently moved to the University of Michigan in Ann Arbor, which meant she was not too far away from them.
Daizha and Dr. Oral
After a few appointments with Dr. Oral, Daizha was officially diagnosed with lipodystrophy. Continue reading →
A microscopic view of norovirus particles. Source: Centers for Disease Control & Prevention
It came on like a thunderbolt, and is still making people sick and miserable across Ann Arbor.
But the norovirus outbreak that put the University of Michigan in the spotlight over the past week may have a silver lining.
Resarchers are working to better understand this virus that sickens tens of millions of Americans each year.
Just last week, a U-M Medical School research team received permission to begin collecting stool samples from people who are experiencing norovirus-like symptoms or just recovered in the past three days.
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.